These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9726704)

  • 21. Aspirin Alone Is Not Enough to Prevent Deep Venous Thrombosis After Total Joint Arthroplasty.
    Woon CYL; Shah RR; Pardi BM; Schwartz BE; Goldstein JM; Cipparrone NE; Goldstein WM
    Orthopedics; 2019 Jan; 42(1):48-55. PubMed ID: 30602046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin.
    Ricket AL; Stewart DW; Wood RC; Cornett L; Odle B; Cluck D; Freshour J; El-Bazouni H
    Ann Pharmacother; 2016 Apr; 50(4):270-5. PubMed ID: 26783354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
    Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
    N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apixaban or enoxaparin for thromboprophylaxis.
    Gómez-Outes A; Suárez-Gea ML; Pozo-Hernández C
    N Engl J Med; 2009 Nov; 361(21):2100-1; author reply 2101. PubMed ID: 19923583
    [No Abstract]   [Full Text] [Related]  

  • 25. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin.
    Yen SH; Lin PC; Kuo FC; Wang JW
    Biomed J; 2014; 37(4):199-204. PubMed ID: 25116715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enoxaparin versus No Anticoagulation Prophylaxis after Total Knee Arthroplasty in Thai Patients: A Randomized Controlled Trial.
    Intiyanaravut T; Thongpulsawasdi N; Sinthuvanich N; Teavirat S; Kunopart M
    J Med Assoc Thai; 2017 Jan; 100(1):42-9. PubMed ID: 29911379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance venous duplex is not clinically useful after total joint arthroplasty when effective deep venous thrombosis prophylaxis is used.
    Schwarcz TH; Matthews MR; Hartford JM; Quick RC; Kwolek CJ; Minion DJ; Endean ED; Mentzer RM
    Ann Vasc Surg; 2004 Mar; 18(2):193-8. PubMed ID: 15253255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inpatient enoxaparin and outpatient aspirin chemoprophylaxis regimen after primary hip and knee arthroplasty: a preliminary study.
    Hamilton SC; Whang WW; Anderson BJ; Bradbury TL; Erens GA; Roberson JR
    J Arthroplasty; 2012 Oct; 27(9):1594-8. PubMed ID: 22480528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan.
    Nagase Y; Yasunaga H; Horiguchi H; Hashimoto H; Shoda N; Kadono Y; Matsuda S; Nakamura K; Tanaka S
    J Bone Joint Surg Am; 2011 Dec; 93(24):e146. PubMed ID: 22258781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of prolonged out-of-hospital prophylaxis with low-molecular-weight heparin following total hip replacement.
    Bergqvist D; Jönsson B
    Haemostasis; 2000; 30 Suppl 2():130-5; discussion 128-9. PubMed ID: 11251357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of switch-therapy modalities (enoxaparin to rivaroxaban/dabigatran) and enoxaparin monotherapy after hip and knee replacement.
    Özler T; Uluçay Ç; Önal A; Altıntaş F
    Acta Orthop Traumatol Turc; 2015; 49(3):255-9. PubMed ID: 26200403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of deep venous thrombosis in the lower extremity after total joint arthroplasty.
    Lotke PA; Steinberg ME; Ecker ML
    Clin Orthop Relat Res; 1994 Feb; (299):25-30. PubMed ID: 8119026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous thromboembolism after lower limb arthroplasty: is chemical prophylaxis still needed?
    Malhotra K; Marciniak JL; Bonczek SJ; Hunt N
    Eur J Orthop Surg Traumatol; 2016 Dec; 26(8):895-899. PubMed ID: 27448284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group.
    Gazzaniga GM; Angelini G; Pastorino G; Santoro E; Lucchini M; Dal Prà ML
    Int Surg; 1993; 78(3):271-5. PubMed ID: 8276557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2017; 106(6):326-327. PubMed ID: 28300001
    [No Abstract]   [Full Text] [Related]  

  • 36. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
    Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
    N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?
    Yokote R; Matsubara M; Hirasawa N; Hagio S; Ishii K; Takata C
    J Bone Joint Surg Br; 2011 Feb; 93(2):251-6. PubMed ID: 21282767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.
    Planes A; Vochelle N; Darmon JY; Fagola M; Bellaud M; Compan D; Saliba E; Weisslinger N; Huet Y
    Drugs; 1996; 52 Suppl 7():47-54. PubMed ID: 9042560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
    Eriksson BI; Dahl OE; Rosencher N; Kurth AA; van Dijk CN; Frostick SP; Prins MH; Hettiarachchi R; Hantel S; Schnee J; Büller HR;
    Lancet; 2007 Sep; 370(9591):949-56. PubMed ID: 17869635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.